Teleflex (NYSE:TFX) Shares Down 5.5% – What’s Next?

Shares of Teleflex Incorporated (NYSE:TFX) dropped 5.5% on Tuesday . The company traded as low as $128.96 and last traded at $128.9490. 64,352 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 832,030 shares. The stock had previously closed at $136.40.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a research note on Monday, April 13th. BMO Capital Markets assumed coverage on shares of Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price target on the stock. Truist Financial restated a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Mizuho set a $140.00 price objective on shares of Teleflex in a research note on Friday, May 8th. Finally, Wells Fargo & Company increased their price objective on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $147.44.

Teleflex Stock Performance

The firm’s 50-day moving average price is $130.02 and its two-hundred day moving average price is $120.17. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The stock has a market cap of $5.82 billion, a price-to-earnings ratio of -5.76, a PEG ratio of 1.01 and a beta of 0.82.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same period last year, the business earned $1.44 earnings per share. Teleflex’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts expect that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were given a $0.34 dividend. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is presently -5.96%.

Institutional Investors Weigh In On Teleflex

A number of institutional investors have recently made changes to their positions in the stock. Empowered Funds LLC increased its holdings in Teleflex by 15.8% in the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares during the last quarter. Jane Street Group LLC boosted its position in shares of Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after buying an additional 1,895 shares during the period. American Century Companies Inc. boosted its position in shares of Teleflex by 32.7% during the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock worth $1,614,000 after buying an additional 3,360 shares during the period. Invesco Ltd. grew its stake in shares of Teleflex by 1.2% in the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after buying an additional 1,659 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Teleflex by 108.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after buying an additional 521 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.